Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry

Current Protocols in Human Genetics

Volumn , Issue SUPPL.76, 2013, Pages

  Zhang, Haoyue ^a   Young, Sarah P ^a   Millington, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dermatan sulfate; Glycosaminoglycans; Heparan sulfate; LC ESI MS MS; Mucopolysaccharidosis

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEXOSAMINE; IDURONIC ACID; KERATAN SULFATE; URONIC ACID; BIOLOGICAL MARKER;

ARTICLE; CARBOHYDRATE ANALYSIS; DIAGNOSTIC VALUE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; ISOTOPE DILUTION ASSAY; MAROTEAUX LAMY SYNDROME; METHANOLYSIS; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SANFILIPPO SYNDROME; SENSITIVITY AND SPECIFICITY; STANDARD; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; BLOOD; CHEMISTRY; LIQUID CHROMATOGRAPHY; METHODOLOGY; QUALITY CONTROL; URINE;

BIOLOGICAL MARKERS; CHONDROITIN SULFATES; CHROMATOGRAPHY, LIQUID; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; KERATAN SULFATE; MUCOPOLYSACCHARIDOSES; QUALITY CONTROL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

MLCS; MLOWN;

EID: 84876740685     PISSN: 19348266     EISSN: 19348258     Source Type: Journal    
DOI: 10.1002/0471142905.hg1712s76     Document Type: Article

References (26)

1. Auclair, D., Finnie, J.,White, J., Nielsen, T., Fuller, M., Kakkis, E., Cheng, A., O'Neill, C.A., and Hopwood, J.J. 2010. Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen. Mol. Genet.Metab. 99:132-141.
2. Auray-Blais, C., Bherer, P., Gagnon, R., Young, S.P., Zhang, H.H., An, Y., Clarke, J.T., and Millington, D.S. 2011. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Mol. Genet. Metab. 102:49-56.
3. Cox-Brinkman, J., Boelens, J.J., Wraith, J.E., O'Meara, A., Veys, P., Wijburg, F.A., Wulffraat, N., andWynn, R.F. 2006. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant. 38:17-21.
4. Cox-Brinkman, J., Timmermans, R.G., Wijburg, F.A., Donker, W.E., van de Ploeg, A.T., Aerts, J.M., and Hollak, C.E. 2007. Home treatment with enzyme replacement therapy for mucopolysaccharidosis type I is feasible and safe. J. Inherit. Metab. Dis. 30:984.
5. de Jong, J.G., Wevers, R.A., Laarakkers, C., and Poorthuis, B.J. 1989. Dimethylmethylene bluebased spectrophotometry of glycosaminoglycans in untreated urine: A rapid screening procedure for mucopolysaccharidoses.Clin. Chem. 35:1472-1477.
6. de Jong, J.G.,Wevers, R.A., and Liebrand-van Sambeek, R. 1992. Measuring urinary glycosaminoglycans in the presence of protein: An improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin. Chem. 38:803-807.
7. Dembure, P.P., Drumheller, J.E., Barr, S.M., and Elsas, L.J. 1990. Selective urinary screening for mucopolysaccharidoses. Clin. Biochem. 23:91- 96.
8. Dickson, P., McEntee, M., Vogler, C., Le, S., Levy, B., Peinovich, M., Hanson, S., Passage, M., and Kakkis, E. 2007. Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid. Mol. Genet. Metab. 91:61-68.
9. Dickson, P., Peinovich, M., McEntee, M., Lester, T., Le, S., Krieger, A., Manuel, H., Jabagat, C., Passage, M., and Kakkis, E.D. 2008. Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I. J. Clin. Invest. 118:2868-2876.
10. Dickson, P.I., Hanson, S., McEntee, M.F., Vite, C.H., Vogler, C.A., Mlikotic, A., Chen, A.H., Ponder, K.P., Haskins, M.E., Tippin, B.L., Le, S.Q., Passage,M.B., Guerra, C., Dierenfeld, A., Jens, J., Snella, E., Kan, S.H., and Ellinwood, N.M. 2010. Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I. Mol. Genet. Metab. 101:115-122.
11. Farndale, R.W., Sayers, C.A., and Barrett, A.J. 1982. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect. Tissue Res. 9:247- 248.
12. Kakkis, E., McEntee, M., Vogler, C., Le, S., Levy, B., Belichenko, P., Mobley, W., Dickson, P., Hanson, S., and Passage, M. 2004. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol. Genet. Metab. 83:163- 174.
13. Mason, K.E., Meikle, P.J., Hopwood, J.J., and Fuller, M. 2006. Characterization of sulfated oligosaccharides in mucopolysaccharidosis type IIIA by electrospray ionization mass spectrometry. Anal. Chem. 78:4534-4542.
14. Muenzer, J. 2004. The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations. J. Pediatr. 144:S27- S34.
15. Muenzer, J. 2011. Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 50:v4-v12.
16. Munoz-Rojas,M.V.,Vieira,T., Costa, R., Fagondes, S., John, A., Jardim, L.B., Vedolin, L.M., Raymundo, M., Dickson, P.I., Kakkis, E., and Giugliani, R. 2008. Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am. J. Med. Genet. A 146A:2538- 2544.
17. Munoz-Rojas, M.V., Horovitz, D.D., Jardim, L.B., Raymundo, M., Llerena, J.C. Jr., de Magalhaes Tde, S., Vieira, T.A., Costa, R., Kakkis, E., and Giugliani, R. 2010. Intrathecal administration of recombinant human N-acetylgalactosamine 4- sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol. Genet. Metab. 99:346-350.
18. Nielsen, T.C., Rozek, T., Hopwood, J.J., and Fuller, M. 2010. Determination of urinary oligosaccharides by high-performance liquid chromatography/ electrospray ionization-tandem mass spectrometry: Application to Hunter syndrome. Anal. Biochem. 402:113-120.
19. Oguma, T., Tomatsu, S., Montano, A.M., and Okazaki, O. 2007. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandemmass spectrometry. Anal. Biochem. 368:79- 86.
20. Ramsay, S.L., Meikle, P.J., andHopwood, J.J. 2003. Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry. Mol. Genet. Metab. 78:193-204.
21. Stone, J.E. 1998. Urine analysis in the diagnosis of mucopolysaccharide disorders. Ann. Clin. Biochem. 35:207-225.
22. Tomatsu, S., Montano, A.M., Oguma, T., Dung, V.C., Oikawa, H., de Carvalho, T.G., Gutierrez, M.L., Yamaguchi, S., Suzuki, Y., Fukushi, M., Kida, K., Kubota, M., Barrera, L., and Orii, T. 2010a. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry. J. Inherit. Metab. Dis.Epub ahead of print.
23. Tomatsu, S., Montano, A.M., Oguma, T., Dung, V.C., Oikawa, H., de Carvalho, T.G., Gutierrez, M.L., Yamaguchi, S., Suzuki, Y., Fukushi, M., Sakura, N., Barrera, L., Kida, K., Kubota, M., and Orii, T. 2010b. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I. J. Inherit. Metab. Dis. 33:141-150.
24. Valayannopoulos, V. andWijburg, F.A. 2011. Therapy for the mucopolysaccharidoses. Rheumatology (Oxford) 50:v49-v59.
25. Zhang, H., Young, S.P., Auray-Blais, C., Orchard, P.J., Tolar, J., and Millington, D.S. 2011. Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandemmass spectrometry. Clin. Chem. 57:1005-1012.
26. Zhou, H., Fernhoff, P., and Vogt, R.F. 2011. Newborn bloodspot screening for lysosomal storage disorders. J. Pediatr. 159:7-13.